Clinical Trials for InhaTarget Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: InhaTarget Therapeutics

Clinical Trials (1)

NCT06896890
Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer
PHASE1/PHASE2Recruiting
32 participants
Started: Jun 23, 2023 · Completed: Oct 1, 2026
2 conditions1 sponsor15 locations